Pelthos Therapeutics Inc.

Net selling: insiders sold $45K and bought $0 of PTHS stock on the open market in the 90 days to Oct 30, 2026, according to SEC Form 4 filings. $45K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Greenleaf, Peter (Director), who sold $17K. The latest filing was on Oct 6, 2026.

None. No member of Congress disclosed a PTHS trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

This summary uses filings available on Oct 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.